Focus Inn, a subsidiary of Santen Pharmaceutical Co., Ltd., is a leading company in the field of ophthalmology. With a history of over a century, Santen has contributed valuable insights to the healthcare industry. Focus Inn specializes in the development of innovative implantable products using their remarkable biomaterial, SIBS, which has great potential in glaucoma surgery. Their commitment to enhancing patients' satisfaction, product safety, and usability is evident in their efforts to address untreated patients and their dedication to research and development. With a focus on sustainability and inclusive society, Focus Inn aims to make a positive impact in the field of ophthalmology.
Generated from the website